79 related articles for article (PubMed ID: 12124245)
21. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
22. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.
Suzuki M; Hattori N; Orimo S; Fukumitsu N; Abo M; Kono Y; Sengoku R; Kurita A; Honda H; Inoue K
Mov Disord; 2005 May; 20(5):634-6. PubMed ID: 15704207
[TBL] [Abstract][Full Text] [Related]
23. Iso-intense gallium uptake in hepatocellular carcinoma: potential pitfalls in diagnosis.
Lee VW; Staffa M
Nucl Med Commun; 1988 Apr; 9(4):309-15. PubMed ID: 2840616
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
25. Unusual diffuse [(131)I]MIBG accumulation in a kidney with renal artery stenosis.
Cortés-Blanco A; Martínez-Lázaro R; Martínez-Duncker C
Nephrol Dial Transplant; 2000 Nov; 15(11):1885-6. PubMed ID: 11071986
[No Abstract] [Full Text] [Related]
26. False-positive In-111 DTPA octreotide scintigraphy resulting from lung abscess in a patient with metastatic neuroendocrine pancreatic neoplasm.
Valero M; Boán JF; Rodriguez-Spiteri N; Torre W; Richter JA
Clin Nucl Med; 2006 Jan; 31(1):20-2. PubMed ID: 16374117
[No Abstract] [Full Text] [Related]
27. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
[TBL] [Abstract][Full Text] [Related]
28. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
29. Diffuse elevated MIBG activity in the renal parenchyma caused by compromised renal blood flow.
Liu B; Codreanu I; Yang J; Servaes S; Zhuang H
Clin Nucl Med; 2014 Nov; 39(11):1005-8. PubMed ID: 24999702
[TBL] [Abstract][Full Text] [Related]
30. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
[TBL] [Abstract][Full Text] [Related]
31. Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction.
Yuyama R; Yuasa F; Hikosaka M; Mimura J; Kawamura A; Hatada K; Motohiro M; Iwasaki M; Sugiura T; Iwasaka T
Clin Physiol Funct Imaging; 2005 Jan; 25(1):34-9. PubMed ID: 15659078
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of 99mTc-PMT in renal metastasis of hepatocellular carcinoma.
Shiozaki T; Hayakawa K; Tanikake M; Oida T; Hida S; Yasui H; Urata Y; Tanaka A; Morimoto T
Ann Nucl Med; 2003 Jun; 17(4):333-6. PubMed ID: 12932119
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
34. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis.
Yoshiike F; Koizumi T; Urushihata K; Hanaoka M; Kubo K
Respiration; 2006; 73(2):191-6. PubMed ID: 16141710
[TBL] [Abstract][Full Text] [Related]
35. Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans.
Monsieurs M; Brans B; Bacher K; Dierckx R; Thierens H
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1581-7. PubMed ID: 12458391
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
[TBL] [Abstract][Full Text] [Related]
37. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
38. Aberrant I-123 MIBG uptake in a gastrointestinal stromal tumour.
van Dellen D; Mitu-Pretorian OM; Augustine T
Updates Surg; 2013 Mar; 65(1):71-6. PubMed ID: 22231492
[No Abstract] [Full Text] [Related]
39. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
[TBL] [Abstract][Full Text] [Related]
40. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.
Anton M; Wagner B; Haubner R; Bodenstein C; Essien BE; Bönisch H; Schwaiger M; Gansbacher B; Weber WA
J Gene Med; 2004 Jan; 6(1):119-26. PubMed ID: 14716684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
